Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute Hearing Loss.

Madhura Tamhankar1, David Solomon

  • 1Departments of Neurology and Neuro-otology, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. dsolomon@mail.med.upenn.edu

Current Treatment Options in Neurology
|December 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: A systematic review and meta-analysis.

Journal of the neurological sciences·2025
Same author

Pre-Registration Mental Health Nursing Students Who Witness Self-Harm Amongst Service Users During Placement: A Cross-Sectional Study.

International journal of mental health nursing·2025
Same author

Exploring erythroid cell transcriptomics to understand regulation of fetal hemoglobin expression for advanced sickle cell disease treatment.

Human molecular genetics·2025
Same author

Early-life clinical and hematological profiles: a comparative study of children with and without sickle cell disease in the first three years of life.

Annals of hematology·2025
Same author

DNA Methylation-Based Classification of Kidney Neoplasms.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2025
Same author

The Efficacy and Safety of Teprotumumab in Geriatrics Patients: A Multicenter Study.

Ophthalmic plastic and reconstructive surgery·2025
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Acute hearing loss (AHL) requires prompt medical attention. Early treatment and diagnosis improve hearing recovery, while idiopathic cases have varied outcomes.

Area of Science:

  • Otolaryngology
  • Neurology
  • Emergency Medicine

Background:

  • Acute hearing loss (AHL) is a medical emergency requiring rapid diagnosis and treatment.
  • Prompt intervention aims to restore hearing by minimizing inner ear ischemia.

Purpose of the Study:

  • To outline the diagnostic and therapeutic strategies for acute hearing loss.
  • To discuss the management of both idiopathic and secondary causes of AHL.
  • To identify prognostic factors influencing hearing recovery.

Main Methods:

  • Initial management involves high-dose corticosteroids (e.g., prednisone) for 10 days.
  • Magnetic resonance imaging (MRI) with gadolinium is recommended for internal auditory canal evaluation.
  • Treatment strategies vary based on the etiology, including medication adjustments, surgical interventions, and supportive therapies.

Related Experiment Videos

Main Results:

  • Idiopathic AHL shows spontaneous improvement in approximately two-thirds of patients within 2 weeks.
  • Specific treatments exist for identifiable causes like ototoxic exposure, infections, or tumors.
  • Management for idiopathic AHL remains controversial, with various agents explored to improve cochlear blood flow and oxygenation.

Conclusions:

  • Early presentation and mild hearing loss (<90 dB) with upward-sloping audiograms are favorable prognostic indicators.
  • Severe hearing loss (>90 dB), flat/down-sloping audiograms, advanced age, and vertigo are adverse prognostic factors.
  • Emerging treatments include interventional procedures and novel drug delivery systems for specific AHL types.